Press Release: Mergers: Commission approves acquisition of parts of Teva by Procter & Gamble

The European Commission has cleared under the EU Merger Regulation the acquisition of important parts of the "over-the-counter" (OTC) business of the pharmaceutical company Teva of Israel by the US company Procter & Gamble (P&G). The Commission concluded that the proposed transaction would not raise competition concerns, because the merged entity would continue to face sufficient competition in the markets concerned.